Potential benefits of a ketogenic diet to improve response and recovery from physical exertion in people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A feasibility study by Cossington, Jo et al.
33 
International Journal of Sport, Exercise and Health Research 2019; 3(2): 33-39 
Research Article 
IJSEHR 2019; 3(2): 33-39 
© 2019, the authors. Licensed 







B.Sc, Department of Sport, 
Health Sciences and Social 
Work, Centre for Movement 
Occupational and Rehabilitation 




Potential benefits of a ketogenic diet to improve response 
and recovery from physical exertion in people with 
Myalgic encephalomyelitis/Chronic Fatigue Syndrome 
(ME/CFS): A feasibility study 
Jo Cossington1, Dr. Shelly Coe2, Yaomeng Liu3, Helen Dawes4 
1 B.Sc, Department of Sport, Health Sciences and Social Work, Centre for Movement Occupational and Rehabilitation 
Sciences, Oxford Brookes University, Oxford, UK 
2 PhD, Department of Sport, Health Sciences and Social Work, Centre for Movement Occupational and Rehabilitation 
Sciences, Oxford Brookes University, Oxford, UK 
3 M.Sc., Department of Sport, Health Sciences and Social Work, Centre for Movement Occupational and 
Rehabilitation Sciences, Oxford Brookes University, Oxford, UK 
4 Professor, Department of Sport, Health Sciences and Social Work, Centre for Movement Occupational and 
Rehabilitation Sciences, Oxford Brookes University, Oxford, UK 
Abstract 
Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) affects approximately 250,000 people in 
the UK. The condition varies in severity causing long-term physical and cognitive fatigue which is not alleviated by rest. 
Whilst the pathology is not understood, recent evidence suggests metabolic abnormalities may be associated with the 
manifestation of symptoms, particularly involving the metabolism of glucose and energy production. The use of ketone 
bodies as an alternative energy substrate may be beneficial to people with ME/CFS, in order to by-pass the glycolytic 
pathway, enhance energy production and reduce fatiguing outcomes. Study Design and Methods: Using a pragmatic 
collective case study with repeated measures methodology we investigated the feasibility of following a ketogenic diet 
and potential effects of the high fat, low carbohydrate diet on response to physical activity in people with ME/CFS (n=3) 
and healthy controls (n=3) using a submaximal exercise stress test both with and without dietary intervention. Exercise 
tolerance (mins), rate of oxygen consumption (VO2) to workload (75W), respiratory exchange ratio (RER), rate of 
perceived effort (RPE) and lactate response were measured throughout and descriptive statistics performed. Results: 
We found that the ketogenic diet was followed, with compliance higher in the pwME/CFS. Variations in response 
following the ketogenic diet was observed across individuals in minutes performed, VO2, HR, RER, and RPE post diet but 
the KD only limited exercise capacity in the control individuals. Individuals responded differently to the KD but group 
trends have been reported as means and standard deviation. The KD resulted in a decrease in RER at submax in the 
controls with a mean change of 0.07 from baseline (0.86 ± 0.1) to post intervention (0.79 ± 0.1) compared to a mean 
change of 0.02 in the ME/CFS from baseline (1.03 ± 0.1) to post intervention (1.01 ± 0.1). A decrease in VO2 (L/min) at 
submax showed a mean change of 0.06 (L/min) in the pwME/CFS at baseline (1.34 ± 0.1) to post intervention (1.27 ± 
0.2) compared to a mean change of 0.07 (L/min) in the controls at baseline (1.40 ± 0.3) to post intervention (1.33 ± 0.2). 
HR (bpm) at submax decreased in all individuals, with a mean change of 4 (bpm), with pwME/CFS at baseline (139 ± 8.2) 
to post intervention (135 ± 14) and control individuals at baseline (107 ± 7.8) to intervention (103 ± 3.2). RPE at submax 
decreased in the pwME/CFS from baseline (6 ± 1.0) to post intervention (5 ± 2.1) whereas the controls increased from 
baseline (2 ± 1.0) to post intervention (3 ± 1.5). Conclusion: Our observations suggest individualised but metabolic 
flexibility in healthy individuals is achievable via dietary manipulation showing the ability to switch from glucose to fats 
under controlled conditions. The different response in substrate utilisation in individuals with ME/CFS suggests that 
potential metabolic abnormalities may be present in ME/CFS. Further investigation is now warranted in order to assess 
whether the KD is beneficial for people with ME/CFS.  
Keywords: Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Ketogenic Diet, Diet, Energy 
Metabolism, Fatigue. 
INTRODUCTION 
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a chronic neurological health condition 
that affects approximately 250,000 people in the UK. It varies in severity, severely impacting on the life 
quality. Symptoms include long-term debilitating fatigue often accompanied by neurocognitive memory 
and concentration impairment; post-exertional malaise (PEM) particularly after physical or mental 
exertion; muscular and joint pain, unrefreshing sleep, flu-like symptoms with tender lymph nodes and sore 
throat [1]. It has a profound impact on the ability to carry out both physical and cognitive activities of 
  
34 
daily living and is not alleviated by rest [2]. 
Whilst the pathology is not completely understood, emerging evidence 
indicates people with ME/CFS (pwME/CFS) have bio-energetic 
impairments which may be related to mitochondrial dysfunction (MD) 
and abnormal substrate metabolism which may associate with the 
manifestation of symptoms [3, 4]. Individuals with ME/CFS show both 
altered energy metabolism during and recovering from physical 
activity. Previous studies have shown pwME/CFS to show reduced 
functional capacity compared to healthy controls during a single VO2max 
test, with reduced time to anaerobic threshold, VO2 peak and workload 
[5-7] with the suggestion that lactate production starts earlier than in 
healthy controls, reducing maximal exercise capacity [8]. Furthermore, 
Nicolson and Ellithorpe [9] previously suggested that pwME/CFS may 
have an increased susceptibility to cellular oxidative stress, resulting in 
the loss of electron transport chain function due to the accumulation 
of reactive oxygen species. Under these conditions, glycolysis would 
increase and result in abnormal lactate production and cellular 
damage. Limited net energy available to cells may therefore result in 
anaerobic metabolism. This was later supported by Booth et al. [10] who 
also suggested that this possible compensatory glycolysis mechanism in 
pwME/CFS results in the need for additional ATP in order to convert 
lactate back to pyruvate. They suggested that a consequently longer 
lactate clearance period and the use of additional ATP for this process 
was unfavourable to such a fatiguing condition and may indeed be 
responsible for an increase in symptoms. 
Importantly, Campagnolo et al’s 2017 [11] systematic review found 
pwME/CFS had an interest in modified diets and supplementation as a 
way to alleviate symptoms, but existing evidence was found to be 
insufficient and lacking as a basis for therapeutic treatment in this 
population group. However, these studies were based on fatigue as the 
primary outcome measured via questionnaires and non-physiological 
biomarkers, the reliance on these methods for measuring fatigue can 
be problematic and often difficult due to subjectivity with differences 
in both cognitive and physical fatigue. Furthermore, they did not 
explore bioenergetics or the impact of the KD.  
To date, no research has examined the responses to and recovery from 
a physical activity stressor in pwME/CFS compared to controls on a KD, 
nor looked at the feasibility of performing such a trial.  
The aim of this foundation study was to assess whether the use of 
ketones as an alternative energy substrate have potential to benefit 
pwME/CFS? This was achieved through the following objectives: to 
evaluate the 1) feasibility of a KD intervention in terms of adherence; 
2) potential benefits or harms to pwME/CFS on performance during 
and recovery from an exercise stress; 3) underpinning mechanism for 
the KD through change in the substrate utilisation  
MATERIALS AND METHODS  
Study Design 
The study was a pragmatic collective case study with a repeated 
measures methodology that lasted for a total of three weeks, with two 
testing visits separated by a one-week self-guided dietary intervention. 
The study was approved by the University Research Ethics Committee, 
reference: 171125. 
Setting 
Assessments were carried out by trained researchers in a University 
setting.  
Participants 
Participants were recruited from the Oxfordshire area via posters 
displayed on University notice boards, online social media posts 
(Twitter) and local ME/CFS support groups. People with a self-reported 
clinical diagnosis of ME/CFS were screened using the Canadian 
Consensus Criteria [2] to confirm diagnosis. The control group was a 
selected convenience sample who showed willingness to participate. 
Further inclusion criteria for both groups included no significant 
current or previous medical history or medical conditions/ 
complications that would preclude safe participation in exercise; no 
other condition affecting the central nervous system other than 
ME/CFS; no known conditions that may be associated with fatigue e.g. 
anaemia; not pregnant; not clinically depressed/ on medication for 
depression. In addition, willingness to adhere to the ketogenic diet was 
also discussed and advice on how to adapt their habitual diet was given 
by a Registered Nutritionist.  
For each visit, the participants were asked to fast overnight 
(approximately 6-8 hours), however they were allowed to drink water. 
Testing sessions took place before 10:00 am and early as feasibly 
possible allowing for flexibility and preference for each participant.  
Order of events 
Visit 1 (Baseline) 
On visit one; participants gave written formal consent according to the 
guidelines laid down in the Declaration of Helsinki.  
Following the ACSM guidelines on safe exercise testing [12] all 
participants were provided with a Physical Activity Readiness 
Questionnaire (PAR-Q), and an electrocardiogram (ECG) was 
undertaken to ensure no cardiac abnormalities would prevent them 
from safely carrying out the exercise test. Any abnormalities would 
have excluded participants from the study at this point.  
Questionnaires were administered to collect basic health information 
and participant demographics. The Fatigue Severity Scale (FSS) was 
used in order to assess fatigue levels. The International Physical 
Activity Questionnaire short form (IPAQ-SF) was used to evaluate 
participant activity levels over the past 7 days. A trained Nutritionist 
took a 24-hour diet recall to collect information on what the 
participants had eaten on the previous day. 
Physical baseline measures were recorded, including height (m), weight 
(kg), heart rate (bpm) and blood pressure (BP). 
Exercise stress response and recovery 
The protocol performed followed that of Mavrommati et al. [13] with 
the work load starting at 10W. In addition, at the end of each 2-minute 
step capillary blood was taken via finger prick for glucose (Precision 
Glucometer) and lactate (Lactate Pro 2, Arkray) levels. In view of the 
broad range of physical impairment and individual fitness levels in the 
ME/CFS group, a set end-point based on meeting maximal criteria was 
not suitable. Therefore, testing was terminated when participants 
reached volitional exhaustion or if their cadence dropped by 10 RPM. 
On ceasing exercise, participants were asked their reason for stopping 
and were encouraged to continue to cycle with no resistance for 1 
minute until their HR had recovered back to baseline. During recovery 
participants were assisted to a chair positioned within 1 meter of the 
cycle ergometer. Continuous lactate, glucose and blood pressure were 
recorded along with rate of perceived effort (RPE) until they reached 
pretest levels.  
Safety  
Each visit lasted around 2 hours to allow for all measures to be taken, 
however due to variation in recovery time this was flexible to ensure 
the participants were fully recovered and felt able to leave. Once 
recovered they, were provided with a snack and transportation home if 
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required. Participants were contacted that evening and the next 
morning to ensure they were not experiencing any adverse effects. 
Dietary intervention 
Following testing on visit 1, participant blood ketone levels were 
checked via finger prick using a blood ketone meter (On Call GK Dual, 
ACON) with expectation that ketone levels were low or 0 mmol/L. 
Participants were then asked to follow a KD for one week consisting of 
~70% fat, ~20% protein and ~10% carbohydrate or <50g of 
carbohydrates a day in order to put them into light nutritional ketosis 
(≥0.5mmol/L). The participants were supplied with ketone urinalysis 
strips (Ketostix, Bayer) and were advised to track their ketone levels 
from day three of the diet (AM and PM) to assess whether they were 
complying with the diet. They were also informed that they could 
contact the Registered Nutritionist if they required further dietary 
advice.  
Due to the possibility of PEM and increased symptoms in the ME/CFS 
group after the exercise test on visit one, a one week wash out period 
was undertaken to allow for sufficient recovery time before 
commencing the KD intervention. If participants required longer, 
allowances were made to ensure participant wellbeing and to ensure 
retention.  
Visit 2 (Post Ketogenic Diet) 
Visit 2 took place after one week of being on the KD. Blood ketone 
levels were checked to assess whether the participants were in a state 
of nutritional ketosis suggested by levels of ≥0.5mmol/L. The repeated 
test was undertaken with the same measures being recorded for 
comparison. Additionally, post exercise ketone levels were also 
recorded to assess whether ketones had been utilised throughout the 
exercise. At the end of the testing session, a Process Evaluation 
questionnaire was administered to determine acceptability of the 
intervention including the ease of adherence to the KD and whether 
there were any perceived benefits.  
RESULTS 
Descriptive statistics were used to compare demographic 
characteristics between groups (Table 1). 
 
Table 1: Baseline participant demographic comparison between groups 
  ME/CFS group Control group 
   (n=3)  (n=3) 
Gender Male: 1/ Female: 2 Male: 2/ Female: 1 
Age 30 ± 6.8 (25-38) 39 ± 11.5 (28-51) 
Weight (kg) 67.8 ± 11 (58-80) 84 ± 13.7 (69-95) 
BMI (kg/m2) 22.3 ± 0.5 (22.1-22.9) 26 ± 4.35 (21.7-28.7) 
V'O2/kg max (ml/min/kg) 29.6 ± 4.9 37.3 ± 8.2 
FSS 5.6 ± 1 1.6 ± 0.7 
IPAQ-SF Moderate High 
Special Diet 1/3 0/3 
Dietary Supplements 3/3 0/3 
Values are expressed as means ± standard deviations, or total number of people within each group. IPAQ-SF is categorised by level of activity. BMI: 
Body Mass Index, VO2max: maximal oxygen uptake, FSS: Fatigue Severity Scale, IPAQ-SF: International Physical Activity Questionnaire-Short Form 
Three ME/CFS participants and three non-ME/CFS controls took part in 
the study. The mean age of the pwME/CFS was 30 (± 6.8) years old in 
comparison to the controls at 39 (± 11.5) years old. Two out of three 
(66%) ME/CFS were female compared to one out of three (33%) of the 
controls. The pwME/CFS were in the healthy BMI range 22.3 (± 0.5) 
whilst the controls had a mean value of 26 (± 4.35) putting them 
collectively in the overweight category for BMI (>25) [14]. 
Observationally it is assumed the participants who were considered in 
the overweight category for BMI were considered to have a high fat 
free mass and low body fat percentage. However, anthropometric 
measures for body composition were not validated upon data 
collection. Mean measures for the Fatigue Severity Scale showed the 
pwME/CFS had a fatigue score of 5.6 (± 1) indicating they suffered with 
fatigue (>4) whereas the controls had a mean score of 1.6 (± 0.7) 
indicating no or very little fatigue [15]. One out of three of the 
pwME/CFS was on a modified Paleolithic diet, limiting dairy and grains. 
All three of the pwME/CFS reported to be taking dietary supplements 
showing they had an interest in dietary modifications in an attempt to 
improve their condition.  
Individual Dietary Intakes  
The 24hr dietary recalls for both the pre and post dietary intervention 
were analysed using Nutritics© software [16] to assess dietary intake 
(total energy, carbohydrate, protein and fat) and to evaluate 
compliance / feasibility to the KD (Table 2).  
 
Table 2: Baseline and post KD measures of macronutrient intake and ketone level 
  Energy (kcal) Carbohydrate (g) Protein (g) Fat (g) Ketones (mmol/L) 
CFS1 Baseline 1345 125 58 69 0 
Post KD 1464 22 93 108 1 
CFS2 Baseline 1472 171 63 60 0 
Post KD 1570 32 92 119 1.2 
CFS3 Baseline 2685 227 149 130 0 
Post KD 3055 42 136 260 0.4 
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Control 1 Baseline - - - - 0 
Post KD - - - - 0.5 
Control 2 Baseline 1739 204 74 67 0 
Post KD 1097 105 54 50 0.5 
Control 3 Baseline 6071 590 301 276 0.2 
Post KD 2871 49 157 220 0.3 
Kcal: kilocalories, g: grams, mmol/L: millimoles per litre, ‘-‘denotes missing data 
The cardio-pulmonary responses for VO2, VCO2, RER and HR were 
analysed using Metasoft Studio (Cortex) software with individual 
responses assessed at a fixed workload of 75 watts to allow for a non-
discriminatory comparison at the same time point (Table 3). Due to 
inter-individual variation in performance time, this enabled a direct 
comparison of output that disregards possible limited exercise capacity 
in the pwME/CFS [5].  
 
Table 3: Group response to exercise stressor at work intensity of 75 watts 
  Visit 1 Baseline Visit 2 Post KD 
  75W 75W 
 ME/CFS group (n=3) Control group (n=3) ME/CFS group (n=3) Control group (n=3) 
V'O2 max (L/min) 1.34 ± 0.1 1.40 ± 0.3 1.27 ± 0.2 1.33 ± 0.2 
V'CO2 max (L/min) 1.34 ± 0.1 1.16 ± 0.2 1.26 ± 0.1 1.03 ± 0.0 
HR (bpm) 139 ± 8.2 107 ± 7.8 135 ± 14 103 ± 3.2 
RER (V’CO2/V’O2) 1.03 ± 0.1 0.86 ± 0.1 1.01 ± 0.1 0.79 ± 0.1 
RPE (1-10) 6 ± 1.0 2 ± 1.0 5 ± 2.1 3 ± 1.5  
Values are expressed as means ± standard deviation. VO2max: maximal oxygen uptake; L/min: litres per minute; VCO2max: maximal volume 
carbon dioxide expired; HR: Heart rate (beats per minute); RER: Respiratory exchange ratio; RPE: Rate of perceived exertion  
 




Considering adherence to the diet in contrast to the controls, all three 
of the pwME/CFS followed the diet successfully, managing to limit their 
carbohydrate intake. From the process evaluation it showed the 
pwME/CFS accepted the diet more so than the controls and were all 
considering continuing the diet after completion of the study. There 
was a consensus that the diet had improved their symptoms, generally 
experiencing less feelings of fatigue, an improvement in energy levels 
and sustained cognitive ability. Importantly, we observed that the 
ketone diet normalised the high levels of glycolytic energy production 
during submaximal exercise activity in individuals with ME/CFS. Our 
findings suggest that ketone diet may enhance submaximal energy 
production during everyday activities and the impact of diet should be 
investigated on cognitive and physical functioning and levels of fatigue. 
Feasibility and Adherence to the Ketogenic Diet 
Figure 1 shows the macronutrient split of the individual dietary intake 
pre KD and on the KD, with missing data for Control 1. 80% (4 out of 5) 
of the participants successfully adhered to the KD, following the 
guidelines of <10% total energy intake and ≤50g carbohydrates per day 
with variation in each individual. However, only 3 out of 5 participants 
were in nutritional ketosis (≥0.5mmol/L) upon arrival on visit 2 (Table 
3). The participant (Control 2) who did not successfully adapt their diet 
(39.2%/ 105g carbohydrate) had ketone levels of 0.5mmol/L, 
suggesting they were in nutritional ketosis. However, their calorie 
intake had reduced by 642kcal from baseline (1739kcal) to intervention 
(1097kcal) resulting in a reduction in energy intake compared to their 
estimated energy requirements (EER) of 2592kcal. Due to such a large 
energy deficit, the total energy and specifically the carbohydrates 
consumed were most likely utilised for energy production, after which 
point they may have entered a fasted state. In addition to the 
overnight fasting requirements this potentially induced increased the 
production of ketone bodies.  
The two participants (CFS3 and Control 3) who had ketone levels 
<0.5mmol/L and were not considered to be in nutritional ketosis 
adhered well to the KD, successfully restricting carbohydrates to 5.5% 
and 7.2% of their total energy intake and were both within the <50g 
recommendation (Table 2) in accordance to the recommended 
guidelines shown in the participant information sheet. However, 
literature suggests that a well formulated KD not only consists of <50g 
of carbohydrates per day but also recommends a moderate protein 
intake of 1.5g/d per kilogram of body weight to successfully increase 
ketone levels [17, 18]. Suggestive that CFS3 and Control 3 exceeded 
guideline protein intake, which may have impacted on the production 
of ketone bodies. Furthermore, under carbohydrate restriction, the 
body metabolises protein producing glucose via gluconeogenesis [19]. 
Therefore, the excess protein intake may have been utilised as an 
energy substrate before lipid oxidation could take place due to the 
hierarchy of fuel selection under these conditions [20].  
CPET (VO2max) and Acute Physical Activity Response 
As expected both pwME/CFS and the controls appeared to adapt to 
lipid metabolism measured by VO2 and an increase in fat burning 
shown by lower CO2 and lower RER at submax post KD (Table 3). If 
glycolytic metabolism is indeed impaired in pwME/CFS the KD may 
have potentially provided a metabolic shift in substrate utilisation that 
enabled an increase in physical activity capacity, enabling them to 
sustain the exercise stressor for a longer time period shown by an 
increase in performance time (Figure 1) and a decrease in RPE from 
baseline to post KD at submax (Table 3).  
In this study, RER values produced by the controls suggest that they 
were utilising lipids at the 75W work rate in comparison to the 
pwME/CFS who were utilising carbohydrates at the same comparable 
work rate (Table 3). These results, alongside the reported hard rate of 
perceived effort, suggest the pwME/CFS were already working close to 
high levels of exertion at the 75W time point which agrees with 
findings by Snell et al. [21] who found pwME/CFS to have higher RER 
levels compared to healthy controls under similar conditions. In 
addition, Snell et al. [21] determined that the relationship between 
higher RER and higher RPE was therefore indeed a true reflection of 
effort and not just an unwillingness to continue to exercise, this 
indicates that the pwME/CFS were indeed closer to maximal exercise 
capacity before the controls. These findings correspond to the 
differences in performance time, with the controls collectively 
performing for longer compared to the pwME/CFS (Figure 1). 
According to Messonnier et al. [22] trained subjects have the capacity to 
oxidise lipids at a higher work rate than untrained subjects. With 
further studies showing those who are more physically active to have a 
lower RER in comparison to those who are more sedentary also at 
comparable workloads [23, 24]. Results from the IPAQ-SF obtained in this 
study placed the pwME/CFS in the moderate category for activity level, 
whereas the controls were in the high category indicating they were 
less sedentary. This suggests there may indeed be a relationship 
between RER and activity levels in these individuals.  
Furthermore, when comparing heart rate (HR) in both pwME/CFS and 
the controls, the pwME/CFS had a higher HR, suggesting they were 
working to full capacity in both tests (Table 3). HR is generally related 
to cardiovascular fitness, exercise intensity and effort [25]. However, it is 
important to highlight pwME/CFS generally appear to have variability 
in HR even at rest compared to healthy controls [21]. Snell et al. [21] 
support the findings that RER is a better predictor of effort in 
pwME/CFS as it disregards any association to HR variability within this 
group, which can be further validated by Van Ness et al. [26] and 
Davenport et al. [27] who found pwME/CFS generally show a blunted HR 
response to exercise at high intensity.  
When comparing the group acute physical activity responses from 
baseline to KD in this study (table 3) it showed both the pwME/CFS and 
the controls experienced a decrease in submaximal RER. Differences in 
the pwME/CFS were not as pronounced, but suggest that the KD could 
provide a metabolic shift in substrate utilisation. RER is an indirect 
measure of substrate utilisation relative to energy expenditure with 
values of ≥1.10 indicating that carbohydrates are being predominantly 
utilised, and lower values of <1.10 indicative of higher levels of fat 
oxidation. Furthermore, RER is also considered an objective measure of 
effort with peaks of >1.10 indicating higher exercise intensity, 
suggestive of time to fatigue and lower values of <1.10 indicating only 
submaximal effort [23, 24]. 
Figure 1 shows inter-individual variation of lactate output. Out of the 
pwME/CFS (Figure 1, A to C) one participant had an increase in lactate 
levels on the KD compared to baseline (A), one participant showed a 
decrease on the KD compared to baseline (B), whilst the third 
participant had a similar lactate response in both tests (C). Two of 
these participants (A and C) reached the same time point on both tests, 
suggesting that neither higher nor lower lactate levels impaired or 
enhanced exercise performance in these individuals with ME/CFS. The 
third participant with the similar lactate output (C) managed to 
exercise for an extra 2 minutes on the KD in comparison to baseline, 
again suggesting that lactate may have not been a limiting factor in 
exercise capability, however this individual produced ketone levels that 
were just under the threshold to be considered to be in nutritional 
ketosis (Table 2).  
In the controls lactate levels decreased in all participants on the KD 
compared to baseline (Figure 1, D to F), with one participant 
experiencing much lower levels on the KD (E). However, there was a 
decrease in peak exercise performance time in all participants (D-F), 
each reaching exercise maximum 2 minutes earlier on the KD in 
comparison to baseline, correlating with an increase in RPE (Table 3). 
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This suggests that the KD impaired exercise performance in the 
controls with feelings of fatigue being experienced sooner, but 
indicates that lactate may have not been the limiting factor for this 
group. Ramos-Jimenez et al. [28] found lower lactate concentrations to 
be suggestive of higher rates of lipid oxidation due to the effects of 
physical activity increasing mitochondrial enzyme activity, driving fatty 
acid oxidation and relative to the reduction of RER. This could suggest 
that the KD may have effectively provided a metabolic shift in 
substrate utilisation in the control group, shown in this study by the 
decrease in RER from baseline to post KD intervention (Table 3). 
However, findings from Fleming et al. [29] demonstrated there to be a 
direct relationship between RPE and blood ketones following high fat 
diets which negatively impacted exercise capacity in non-trained 
individuals, supported by White et al. [30] who found blood ketone 
concentrations were directly related to feelings of fatigue. 
The pwME/CFS produced lower VO2 values (Table 3) at both baseline 
and post KD compared to the controls, indicating they had less aerobic 
capacity. Once maximal O2 uptake is reached, anaerobic metabolism 
becomes the predominant metabolic pathway for energy production, 
resulting in the production of lactate and the onset of fatigue [20], this 
indeed corresponds with the results obtained in this study from the 
individuals, with the pwME/CFS reaching maximum capacity before the 
controls, with higher levels of lactate, RER and RPE. This has previously 
been demonstrated by Riley et al. [31] who found higher lactate 
concentrations, HR and RPE in pwME/CFS compared to controls at the 
same workloads. Importantly, if VO2 is reached at much lower levels of 
O2 consumption in pwME/CFS suggesting they are indeed more 
anaerobic, it could highlight a relationship between fatigue and 
symptom exacerbation and PEM experienced after only light exercise 
and/or activities of daily living if O2 thresholds can be exceeded at such 
low levels [21].  
Carbohydrate restriction is important to consider for all individuals 
performing exercise due to reduced tissues glycogen stores [32]. 
Following the KD intervention, the minimal carbohydrate intake may 
have impacted muscle glycogen stores with little or none available for 
energy. Once depleted, individuals would naturally find it difficult to 
sustain exercise, limiting physical performance and causing fatigue [33, 
34]. However, it was predicted the ketones should have physiologically 
driven fat oxidation to provide energy, additionally further 
consequences of limited glucose availability involves a reduced 
capacity of the Krebs cycle for energy production relating to a limited 
availability of intermediates for fat oxidation [35].  
Limitations 
The ME/CFS sample used in the study cannot be considered 
representative of the population group as a whole, due to different 
levels of severity experienced in those with ME/CFS. Only individuals 
who were able to partake in the exercise test were included in the 
study, a difficulty experienced in previous research by Snell et al. [21]. 
This resulted in difficulty to recruit due to the nature of the exercise 
test possibly exacerbating symptoms and causing PEM in the 
pwME/CFS. However, the pwME/CFS that took part did not report any 
additional symptoms that were atypical of their condition following the 
exercise testing. The wash out period following the first test and 
commencement of the KD was used to ensure the participants had 
fully recovered and to differentiate between the possible adverse 
effects of the KD. This would be recommended for future work to 
ensure participant wellbeing and safety and to reduce the risk of 
participant drop out. Limited recruitment time resulted in low 
participation making it difficult to conclude at whether the KD had a 
significant effect on the population group nor is it representative to 
assume any benefits.  
CONCLUSION 
Data collected in this study enabled feasibility to be assessed 
specifically in relation to the testing methods used considering the 
possibility of limited exercise capacity in the ME/CFS group and further 
showed that compliance to the KD was obtainable to the majority of 
participants and in all participants with ME/CFS. Our findings suggest 
there may be potential changes in submaximal energy utilization, and 
further work to investigate these responses is now warranted to assess 
whether the use of ketones as an alternative energy substrate are 
beneficial in this condition, and to assess the potential of the KD in 
relation to symptom management. 
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